Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 60.39B 1,270B | Sales 2025 * | 16.35B 62.23B 1,309B | Capitalization | 15.64B 59.55B 1,252B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 5.86B 123B | Net income 2025 * | 1.44B 5.49B 115B | EV / Sales 2024 * | 1.91 x |
Net Debt 2024 * | 14.62B 55.67B 1,171B | Net Debt 2025 * | 12.12B 46.13B 970B | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
10.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 31/12/22 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 21/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 31/08/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 08/06/20 |
Sol Barer
CHM | Chairman | 76 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |